top of page
Writer's pictureNikki Elmi
Aug 63 min read

Crystal Hands: Understanding Gout and CPPD

By Nikki Elmi


Gout is a type of arthritis known for its sudden, severe attacks of pain, redness, and tenderness in joints, most commonly affecting the big toe. It's caused by the accumulation of urate crystals within the joint, which leads to inflammation and intense pain. CPPD (Calcium Pyrophosphate Deposition Disease), often referred to as pseudogout, is a similar condition where calcium pyrophosphate crystals accumulate in the joints, causing pain and swelling.



Gout arises from hyperuricemia—an excess of uric acid in the blood. Uric acid is a waste product formed from the breakdown of purines, substances found in certain foods and drinks. When uric acid levels become too high, it can crystallize and deposit in the joints. Factors such as a diet rich in purines (red meat, seafood), alcohol consumption, obesity, and genetics can increase the risk of gout. In contrast, CPPD occurs due to the deposition of calcium pyrophosphate crystals. The precise cause of CPPD is less clear, but it's often associated with aging, joint trauma, genetic predisposition, and metabolic diseases like hemochromatosis and hyperparathyroidism.



Diagnosing gout involves a combination of clinical assessment, blood tests to measure uric acid levels, and imaging techniques such as X-rays or ultrasounds to detect crystal deposits. A definitive diagnosis is made through joint fluid analysis, where urate crystals can be directly observed under a microscope. For CPPD, similar diagnostic approaches are used, including joint fluid analysis, which reveals calcium pyrophosphate crystals. Imaging studies can show chondrocalcinosis (calcification in the cartilage), which is indicative of CPPD.




Treatment for gout focuses on managing acute attacks and preventing future episodes. During an acute gout attack, NSAIDs (nonsteroidal anti-inflammatory drugs), corticosteroids, and colchicine are commonly used to reduce inflammation and pain. Long-term management includes lifestyle modifications such as dietary changes to lower purine intake, reducing alcohol consumption, and weight loss. Medications like allopurinol or febuxostat are prescribed to lower uric acid levels and prevent future attacks. For CPPD, treatment similarly involves NSAIDs and corticosteroids to manage acute symptoms. Long-term management may include addressing underlying conditions, physical therapy to maintain joint function, and in some cases, medications like colchicine to prevent recurrent attacks.



Both gout and CPPD are types of crystal-induced arthritis that cause significant pain and inflammation in the joints. Accurate diagnosis and appropriate treatment are essential to manage these conditions effectively and improve patients' quality of life. By understanding the underlying mechanisms, risk factors, and treatment options, individuals can better manage their symptoms and prevent future flare-ups, ensuring better long-term joint health and overall well-being.




References:




Assessed and Endorsed by the MedReport Medical Review Board



bottom of page